Profil
Andrew John Scott Walton-Green is currently the Chairman at Biosceptre (Aust) Pty Ltd. and Biosceptre International Ltd. He is also a Director at Project Better Energy Ltd. In the past, he served as the Chief Executive Officer at Gresham Technologies Plc from 2000 to 2010.
Aktive Positionen von Andrew Walton-Green
| Unternehmen | Position | Beginn |
|---|---|---|
Biosceptre (Aust) Pty Ltd.
Biosceptre (Aust) Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops oncology immunotherapies for applications in the diagnosis and treatment of cancer | Vorsitzender | 20.12.2018 |
Biosceptre International Ltd.
Biosceptre International Ltd. BiotechnologyHealth Technology Operates as biotechnology company which develops cancer therapeutics and multiple drugs | Vorsitzender | 01.12.2014 |
Project Better Energy Ltd.
Project Better Energy Ltd. Electric UtilitiesUtilities Engages in generating electric power | Direktor/Vorstandsmitglied | 31.03.2014 |
Ehemalige bekannte Positionen von Andrew Walton-Green
| Unternehmen | Position | Ende |
|---|---|---|
| GRESHAM TECHNOLOGIES | Präsident | 28.04.2010 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Gresham Technologies Plc
Gresham Technologies Plc Information Technology ServicesTechnology Services Provides data integrity, reconciliation and enterprise data automation solutions for global financial institutions | Technology Services |
Biosceptre (Aust) Pty Ltd.
Biosceptre (Aust) Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops oncology immunotherapies for applications in the diagnosis and treatment of cancer | Health Technology |
Project Better Energy Ltd.
Project Better Energy Ltd. Electric UtilitiesUtilities Engages in generating electric power | Utilities |
Biosceptre International Ltd.
Biosceptre International Ltd. BiotechnologyHealth Technology Operates as biotechnology company which develops cancer therapeutics and multiple drugs | Health Technology |
















